http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 27 Jul 2026 11:17:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++NEUROCRINE+BIOSCIENCES+++++++++++++++++Filed+by%3A+JPMORGAN+CHASE+%26amp%3B+CO/26817824.html si-local-file:///var/storage/secattach/20260727/26817824.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++NEUROCRINE+BIOSCIENCES+++++++++++++++++Filed+by%3A+JPMORGAN+CHASE+%26amp%3B+CO/26817824.html Mon, 27 Jul 2026 11:17:00 -0400 NBIX O.00172349 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++NEUROCRINE+BIOSCIENCES+++++++++++++++++Filed+by%3A+JPMORGAN+CHASE+%26amp%3B+CO/26817824.html si-local-file:///var/storage/secattach/20260727/26817824.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++NEUROCRINE+BIOSCIENCES+++++++++++++++++Filed+by%3A+JPMORGAN+CHASE+%26amp%3B+CO/26817824.html Mon, 27 Jul 2026 11:17:00 -0400 NBIX O.00172349 http://www.streetinsider.com/Corporate+News/Neurocrine+Biosciences+names+three+senior+vice+presidents/26808024.html <p>Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced the appointment of three Senior Vice Presidents, according to a press release dated July 23, 2026.</p><p>Bret Paulson joins the company as Senior Vice President of Market Access. He brings nearly 30 years of experience in the biopharmaceutical and insurance industries, most recently serving as Vice President and Head of Market Access and Channel Strategy at Otsuka Pharmaceutical Companies.</p><p>David Bradfute, who joined Neurocrine in 2017, was promoted to Senior Vice President and Global Head of Intellectual Property. He will also serve as Managing Director of Neurocrine Switzerland GmbH, based in Basel, Switzerland. Before joining Neurocrine, http://www.streetinsider.com/Corporate+News/Neurocrine+Biosciences+names+three+senior+vice+presidents/26808024.html Thu, 23 Jul 2026 16:06:04 -0400 NBIX http://www.streetinsider.com/Management+Changes/Neurocrine+Biosciences+names+three+senior+vice+presidents/26808024.html <p>Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced the appointment of three Senior Vice Presidents, according to a press release dated July 23, 2026.</p><p>Bret Paulson joins the company as Senior Vice President of Market Access. He brings nearly 30 years of experience in the biopharmaceutical and insurance industries, most recently serving as Vice President and Head of Market Access and Channel Strategy at Otsuka Pharmaceutical Companies.</p><p>David Bradfute, who joined Neurocrine in 2017, was promoted to Senior Vice President and Global Head of Intellectual Property. He will also serve as Managing Director of Neurocrine Switzerland GmbH, based in Basel, Switzerland. Before joining Neurocrine, http://www.streetinsider.com/Management+Changes/Neurocrine+Biosciences+names+three+senior+vice+presidents/26808024.html Thu, 23 Jul 2026 16:06:04 -0400 NBIX http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841 http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>July 23, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4737315-1&amp;h=3039311840&amp;u=https%3A%2F%2Fwww.neurocrine.com%2F&amp;a=Neurocrine+Biosciences%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:NBIX" idsrc="xmltag.org" >Neurocrine Biosciences, Inc.</span></a> (Nasdaq: NBIX) today announced the appointment of three Senior Vice Presidents, further strengthening its leadership team as the company executes its next phase of growth, expands its commercial portfolio and advances one of the industry's strongest neuroscience pipelines. These appointments reflect Neurocrine's continued evolution into a diversified, multi-product biopharmaceutical company positioned to deliver sustainable long-term growth.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Neurocrine+Biosciences+Announces+Key+Leadership+Hiring%2C+Promotions/26807989.html Thu, 23 Jul 2026 16:05:00 -0400 A.11608963 A.11888053 A.17530805 A.21873776 A.22637628 A.27280295 A.34216841 A.34684790 A.37966080 A.41027337 A.41168036 A.50202654 NBIX O.00171633 O.00172349 O.00176505 O.00384685 O.00812780 O.01689215 O.02097096 O.05010326 O.13110865 O.19974150 O.26149194 O.35379884 O.58458841